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ABSTRACT
PURPOSE: To evaluate the efficacy and side-effects of fentanyl and sufentanil combined with hyperbaric spinal bupivacaine in elective 
cesarean section. 
METHODS: A prospective, randomized, double-blind study with 64 term parturients, distributed into 2 groups according to the opioid 
combined with hyperbaric bupivacaine 0.5% (10mg): GF - fentanyl (25µg) and GS - sufentanil (5.0µg). The latency and maximum 
sensory block level; degree and duration of motor block; duration and quality of analgesia; maternal-fetal repercussions were evaluated. 
This was an intention-to-treat analysis with a 5% significance level. 
RESULTS: The latency period, maximum sensory block level, motor block degree and perioperative analgesia were similar in both 
groups. Motor block and analgesia had a longer duration in the sufentanil group. Maternal adverse effects and neonatal repercussions 
were similar. The incidence of hypotension was higher in the fentanyl group. In both groups, there was a predominance of patients who 
were awake and either calm or sleepy.
CONCLUSIONS: The addition of fentanyl and sufentanil to hyperbaric subarachnoid bupivacaine was shown to be effective for the 
performance of cesarean section, and safe for the mother and fetus. Analgesia was more prolonged with sufentanil.   
Key words: Anesthetics. Combined Subarachnoid Space. Analgesics, Opioid. Fentanyl, Sufentanil. Anesthetics, Local. Bupivacaine. 
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Introduction
Hyperbaric bupivacaine is a commonly used local 
anesthetic in spinal anesthesia for elective or emergency cesarean 
section. However, the use of the local anesthetic alone is associated 
with a short duration of action and infrequent occurrence of 
nausea in the intraoperative period during uterine and peritoneal 
manipulation1,2. Hyperbaric bupivacaine is frequently employed in 
doses ranging from 4.0 to 15 mg. Doses below 10 mg used alone 
or 8.0 mg combined with  an opioid are considered low doses of 
local anesthetics2-6. 
The use of intrathecal opioids in combination with a 
local anesthetic has gained popularity in the last decades, since 
it is related to better intraoperative and postoperative analgesia. 
Furthermore, there is a decrease in local anesthetic dose, 
minimizing the risk of maternal arterial hypotension and damage 
to the fetus2-4,6-9.
The aim of this study was to comparatively assess 
the effects of sufentanil or fentanyl combined with hyperbaric 
bupivacaine on quality of the block and maternal/neonatal 
repercussions in parturients scheduled for cesarean section under 
spinal anesthesia, 
Methods
The study was performed after approval from the 
Medical Research Ethics Committee (CONEP – Platform Brazil) 
of the Institution (Protocol 006/2013) and written informed 
consent from all subjects. This is a randomized double-blind 
clinical trial, including 64 term consecutive parturients, with a 
single fetus, ASA physical status 1 and 2, scheduled for elective 
cesarean section, under spinal anesthesia. Criteria of exclusion: 
ASA physical status 3 and 4, prematurity, multiple pregnancy, 
preeclampsia, diagnosis of acute or chronic fetal distress, age 
< 18 years, body mass index (BMI) > 40, psychiatric disorder, 
drug addiction, contraindication to regional anesthesia, 
history of hypersensitivity to drugs employed and previous 
administration of opioids and/or other central nervous system 
(CNS) depressants. 
Sample size estimates were based on the results by 
Braga et al.6 and Karaman et al.9, considering a total duration 
of analgesia (minutes) of 196 ± 69 (bupivacaine and sufentanil) 
and 252 ± 234 (bupivacaine and fentanyl), with a difference of 56 
minutes between the mean. Assuming this difference by Student’s 
t test, and considering a 5% level of significance (α=0.05) and 
80% power (β =20%), a sample of 23 cases was required in each 
group. To compensate for eventual losses, 32 patients randomly 
allocated by lot were included in each group. For this purpose, a 
sealed standardized box was used at the beginning of the study. 
In both groups, 10 mg of hyperbaric bupivacaine 0.5% (2 
mL) was employed. In Group F, 25 µg of fentanyl was added to the 
solution (0.5 mL) and 0.5 mL of saline (SF) 0.9 %, to complete a 
total volume of 3 mL. In group S, 5 µg sufentanil (1 mL) was added. 
The Anesthesiologist who performed the spinal block and a second 
Anesthesiologist responsible for data collection were blinded to the 
solution used.  The drugs used were products originating from the 
same manufacturer, without determining the lot. 
All parturients were fasted and did not receive 
premedication. In the operating room, all patients received 
continuous monitoring with ECG in DII lead, pulse oximetry and 
noninvasive arterial blood pressure measurement. Prior to the start 
of spinal injection, an intravenous catheter was placed for infusion 
of 500 to 750 mL of a lactated Ringer’s solution. With patients in 
the sitting position, lumbar puncture was performed at the L3-4 or 
L2-3 interspace, using a Whitacre 27G pencil-point needle with 
atraumatic bevel. In cases of difficult lumbar puncture, a Quincke 
25G cut-bevel needle was used. After confirmation of CSF reflux, 
the anesthetic solution was injected at a rate of 1.0 mL.15s-1. After 
spinal injection, the patients were moved into the supine position 
with left uterine displacement (using a Crawford wedge), until 
birth. Oxygen was administered with a nasal catheter (3L.min-1). 
A lactated Ringer’s solution (10mL.Kg-1.hour-1) was used for fluid 
management. 
The following parameters were studied: 1) sensory block 
latency - time from the end of anesthetic subarachnoid injection 
to loss of pinprick sensation T10; 2) maximum sensory block 
level; 3) maximum motor block degree, assessed according to a 
modified Bromage score: 0 = free movement of the lower limbs 
(nil); 1 = able to flex knees and move feet; 2 = able to flex feet; 3 
= complete lower limb immobility; 4) time for motor regression 
- time from the end of  subarachnoid anesthetic injection to 
free lower limb movement (0 - nil); 5) duration of analgesia 
- time from the end of subarachnoid anesthetic injection to 
first report of pain (VNS ≥ 3) spontaneously reported by the 
patient; 6) maternal cardiovascular and respiratory  parameters: 
mean arterial pressure (MAP - mmHg), heart rate (HR - 
bpm), respiratory rate (RR - breaths per minute) and oxygen 
saturation (SpO2 - %), assessed at the following time points: 
before block (M0); immediately after block (M1);  every five 
minutes during surgery (M2); end of surgery (M3); 7) level of 
consciousness in the intraoperative period according to a score 
proposed by Filos et al.10  and  modified by Braz et al.11: 1= 
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awake (anxious, agitated); 2= awake (calm); 3= somnolent; 
4=sleeping (awake with verbal stimulation); 8) maternal 
side-effects in the intraoperative: nausea, vomiting, pruritus, 
respiratory depression (SpO2 ≤ 90% and respiratory rate lower 
than 10 breaths per minute); 9) neonatal repercussions: using 
the Apgar score at the first and five  minutes.
Intravenous benzodiazepine (midazolam - 1 to 2 mg) 
and/or opioid (fentanyl -100 µg) were used for supplementation 
in intraoperative anxiety, pain or partial failure of block, 
whenever required. In complete failure of block, general 
anesthesia was induced. Urinary retention was not evaluated, 
since all postoperative patients were maintained with Foley 
catheterization.
Arterial hypotension was defined as a mean arterial 
pressure below 70 mmHg. If present, it was treated with rapid 
crystalloid infusion. If hypotension persisted, ephedrine was used 
(5mg - IV bolus). Bradycardia was defined as a decrease in heart 
rate to values below 50 beats per minute and was treated with 
atropine (10-20µg.kg-1). 
Time for the beginning of surgery, total duration of the 
procedure, fetal extraction and surgical duration (minutes) were 
respectively defined as: time from the end of spinal induction to 
beginning of surgery and end of surgery; from skin incision to 
placental delivery, and end of surgery.
Intention-to-treat analysis was conducted and the 
frequency distribution of control variables in both groups 
were evaluated to verify their comparability. For analysis of 
patient characteristics, sensory block latency period, duration of 
analgesia, and the time for motor block regression, the Student’s 
t test was used; to study for motor block degree, sensory block 
level, ephedrine requirement, maternal side-effects and level of 
consciousness; incidence of hypotension, the chi-square test was 
used; for intraoperative discomfort, the Fisher exact test was 
used. For statistical analysis of cardiovascular and respiratory 
parameters, M2 time point was considered the mean value 
obtained at 5-minute intervals during surgery and the MANOVA 
test was used. The level of significance was 5%. 
Results
Analysis of anthropometric data showed that there was 
no significant difference between the groups. Values of mean and 
standard deviations are in Table 1.  Regarding (ASA) physical 
status, ASA class 2 patients were shown to predominate in group 
F, without a significant difference. In both groups, repeat cesarean 
delivery was the main indication for surgery. 
The means and standard deviations of surgical 
duration, fetal extraction time and total time were similar. 
However, the time between the end of spinal injection and the 
beginning of surgery was significantly longer (p=0.007) in the 
sufentanil group (Table 2).   
 Fentanyl 
(n=32)
Sufentanil 
(n=32)
p
Age (years)* 31.56  ±  6.05 29.40 ± 6.46  0.26
Weight (Kg)* 79.86  ± 11.8 78.85 ± 12.9  0.45
Height (m)* 1.57   ±  0.06 1.59  ± 0.07  0.25
BMI (kg.m -2)* 31.73 ± 4.79 31.36 ± 4.76  0.23
ASA (1:2) 12:20 17:15
TABLE 1 - Anthropometric data.
Values expressed in mean ± SD and number of  patients
* Student’s t test
 Fentanyl Sufentanil p
Time for the beginning 
of surgery (min.)*
13.84 ± 2.14 15.81 ± 3.64 0.0073
Fetal extraction  
time (min.)*
17.03 ± 6.35 17.03 ± 5.35 0.5
Duration of  
surgery (min.)*
75.06 ± 21.87 76.06 ± 17.10 0.42
Total time (min.)* 88.90 ± 22.59 91.81 ± 16.99 0.27
TABLE 2 - Surgery characteristics.
Values expressed in mean ± SD
* Student’s t test
Latency period and maximum sensory block level were 
similar between groups, with no statistical difference. Maximum 
sensory block level ranged from T2 to T6, with a predominance of 
T4 (81.25% of cases in both groups). Motor block degree varied 
between 2 and 3, with a predominance of grade 3. Time for motor 
block regression and total duration of analgesia was significantly 
longer in the sufentanil group.  Data on block characteristics are 
in Table 3.
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Complete failure of block that would have required 
conversion to general anesthesia did not occur in this study. None 
of the cases was discontinued from the study, due to need of a new 
block. Intraoperative pain (VNS ≥ 3) was reported by four patients 
from group F, at 78, 91, 96, 120 minutes and by three patients from 
group S at 71, 80, and 92 minutes, respectively.  In these cases, 
intravenous fentanyl (100 µg) and midazolam (2.0 mg) were used. 
In both groups, changes in hemodynamic parameters were 
similar. There was no significant difference between mean MAP 
and HR values, in different time points evaluated. On individual 
analysis of MAP values, values below 70 mmHg were observed 
in 24 patients (75%) from group F and 12 (37.5%) from group S, 
with a significant difference (p=0.005). Episodes of hypotension 
occurred five minutes after terminating anesthetic spinal injection 
and the mean value ± SD of MAP was 69.89 ± 16.05 and 72.97 ± 
16.63 in groups F and S, respectively. Ephedrine was administered 
at a dose ranging from 5 to 30 mg. The mean ephedrine  dose 
in groups F and S was 15.41 ± 9.64 mg and 13.69 ± 8.55 mg, 
respectively, with no significant difference (p=0.60). Ephedrine 
was required by 24 patients in group F and 12 patients in group S, 
with a significant difference (p= 0.005). In both groups, individual 
analysis of HR values, showed no values below 50 bpm.
All patients maintained respiratory rates above10 breaths 
per minute and SpO2 between 95 and 100%. In both groups, the 
Apgar score ranged from 8 to 9 at the first and fifth minute. All 
newborn infants received Apgar 10.  The incidence of maternal 
side-effects in the intraoperative period is shown in Table 4 and was 
similar in both groups. Pruritus was the most common maternal 
adverse effect, with no significant difference (p= 0.568). Naloxone 
was used for management of this complication in two patients from 
group F and one from group S, without compromising analgesia.
 Fentanyl Sufentanil p
Onset of sensory 
block (min)*
3.12 ± 0.70 3.37 ± 1.07 0.48
Maximum level of 
sensory block**
T2    05 (15.62%)      04 (12.5%) 0.4
T4    26 (81.25%)      26 (81.25%) 0.45
T6     01 (3.12%)       02 (6.25%) 0.6
Total duration of 
analgesia (min) *
177.21 ± 51.10 210.71 ± 80.10 0.014
Degree of motor 
block**
2  0  (0%)       03 (9.37%) 0.54
3 32 (100%) 29 (90.62%) 0.44
Time for motor block 
regression (min)*
165.06 ± 44.17 189.56 ± 73.52 0.038
TABLE 3 - Block characteristics.
Values expressed in mean ± SD; number (n) and percentage of patients (%)
* Student’s t test
Fentanyl Sufentanil
Nausea 08 (25%) 08 (25%)
Vomiting   02 (6.25%)  04 (12.5%)
Pruritus    14 (43.75%) 17 (53.12%)
TABLE 4 - Adverse effects.
Values expressed in number (n) and percentage of patients (%)
Concerning level of consciousness in both groups there 
was a predominance of patients who were awake and calm or 
somnolent.  
Discussion
Lipophilic opioids have a favorable pharmacological 
profile for use in spinal anesthesia, in comparison to hydrophilic 
opioids. Lipophilic opioids have a rapid onset of action, moderate 
duration, and a lower tendency to migrate rostrally to the 4th 
ventricle, resulting in a lower risk of ventilatory depression12-14. 
Although the analgesic potency of intrathecal local anesthetics is 
augmented when used in combination with different opioids, it is 
important to highlight that the minimum effective dose of opioid 
should be used in cesarean section to minimize maternal and 
neonatal adverse effects1. 
Among lipophilic opioids, there is no consensus over the 
optimal fentanyl dose in spinal anesthesia for cesarean section, 
despite its wide use. Several studies using different doses of 
fentanyl (6.25 to 50µg), combined with intrathecal hyperbaric 
bupivacaine for cesarean delivery, have demonstrated good results 
regarding quality of intraoperative anesthesia and postoperative 
analgesia1,9,12,15-17. Chu et al.15 assessed the effectiveness of 
incrementing doses of fentanyl (0 - 15 µg) combined with 
bupivacaine and observed complete, effective and  prolonged 
analgesia, with  doses  above 10 µg, compared to a group given 
7.5 µg.  Those authors concluded that a dose of 10 µg was adequate 
for satisfactory intraoperative analgesia and 12.5 µg for more 
prolonged postoperative analgesia. These results are contrary to 
findings by Hunt et al.18 who evaluated the effects of various doses 
of fentanyl (6.25 to 50 µg) combined with hyperbaric bupivacaine 
for cesarean delivery. Although perioperative analgesia was 
adequate in all doses studied, those authors described that the 
effective fentanyl dose was 6.25 µg, since higher doses did not 
contribute to prolong the duration of analgesia.  
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Satisfactory analgesia was observed in the intraoperative 
and postoperative period in this study, similarly to previous 
studies9,17,19  where a dose of 25 µg fentanyl was also used. 
However, the longer time to report pain (VNS ≥ 3) described in 
other studies may be attributed to the use of higher bupivacaine 
doses than those used in our study. 
In the last decades, the increased use of spinal sufentanil 
in combination with local anesthetics has been observed1,2,5-7,20-23 
. In spinal blocks for labor analgesia and cesarean section, it has 
been described that the potency of sufentanil is increased around 
4.5 to 5-fold in comparison to the potency of fentanyl, prolonging 
the duration of postoperative analgesia1,24-25. These results are 
contrary to those found by Lee et al.22  who observed no difference 
in the duration of analgesia, when using 20 µg of fentanyl and 2.5 
µg of sufentanil. 
In this study, the dose used (5.0 µg sufentanil) been 
previously described by other authors5 as adequate for satisfactory 
intraoperative and postoperative analgesia without any maternal-
fetal repercussions. Those authors studied the effectiveness of 
different doses of sufentanil (0, 2.5, 5.0 and 7.5 µg) in combination 
with bupivacaine in patients scheduled to cesarean section under 
subarachnoid block. A dose of 5.0 µg sufentanil produced better 
results than a 2.5 µg dose. No additional effect was obtained with 
a higher dose (7.5 µg). 
In both groups studied, the use of equipotent doses of 
both opioids provided satisfactory and similar intraoperative 
analgesia. Nevertheless, total duration of analgesia and time for 
motor block regression were significantly longer in the sufentanil 
group, in comparison to the fentanyl group. Vyas et al.26 obtained 
analgesia with a duration of 184.0 minutes using a dose of 5 µg 
sufentanil, while Trivedi and Jha27 demonstrated a 156% increase 
in the mean duration of analgesia, in comparison to analgesia 
obtained with fentanyl (305 ± 48.95 versus 195 ± 19.39). The 
more prolonged time in the sufentanil group may be related to its 
high stereospecificity. Sufentanil has a higher affinity for the µ 
receptor than fentanyl24,25. 
In our study, pain was reported by four patients who 
received fentanyl and three patients from the sufentanil group, 
occurring at a mean time of 96 and 81 minutes, respectively. 
Considering that the surgical procedures were performed by 
physicians-in-training, surgical time reflects the characteristics 
of the health care facility. In our study, it exceeds the surgical 
time described in the literature, which is between 45 and 60 
minutes9,17,23,26. Another factor corroborating to a longer surgical 
time may have been the indication for the procedure, which was 
repeat cesarean delivery in virtually half the patients in each group. 
In cesarean delivery, the incidence of arterial hypotension 
associated with spinal blockade is around 50 to 85%7,23. Despite 
similarity between groups, regarding sensory block level and 
latency period, individual analysis showed that arterial hypotension 
was present in a larger number of patients in the fentanyl group 
(75%) than in the sufentanil group (37.5%). These changes occurred 
immediately after spinal injection and were promptly controlled by 
left uterine displacement, volume expansion and ephedrine. Thus, 
newborn infants showed no signs of fetal distress. Our results were 
similar to those described in the literature, proving that the drug 
combination is safe in the doses used7,9,19,21,28.  
Nausea and pruritus were the most frequently found 
adverse effects in both groups, results similar to those described in 
the literature 5,19,23. Although the occurrence of nausea and vomiting 
during cesarean section is considered relevant, and frequently 
related to uterine exteriorization and peritoneal exposure, it has 
been currently described that opioids given intrathecally may confer 
protection against such adverse effects9. In a systematic review, Dahl 
et al.28 reported that the incidence of nausea and vomiting did not 
increase with the use of fentanyl and sufentanil, in agreement with 
findings by other authors1,26. Those authors described that antiemetic 
agents were required only in groups where the local anesthetic was 
used alone. This may confirm the theory that lipophilic opioids 
may offer a protective effect. In our study, the incidence of nausea 
was 25% in both groups, similarly to the results presented by 
Bang et al.23. However, the results differed from those observed 
in other studies17,26 which described a lower incidence. The lower 
incidence of nausea may be attributed to previous administration of 
metoclopramide, ranitidine and ramlidine. 
Pruritus was directly related to the opioid dose 
administered intrathecally. Studies have described incidence 
rates of pruritus reaching 62%, 67% and 80% with intrathecal 
morphine, fentanyl and sufentanil, respectively28,29.  In agreement 
with other studies8,9,28,29, pruritus was the most common side-effect 
found in our study. However, there was no difference between 
both opioids. The mechanisms responsible for the emergence of 
pruritus remain unclear. However, an encephalinergic mechanism 
has been proposed to explain the presence of pruritus, with an 
“itch” center in the Central Nervous System and activation of 
the medullary dorsal horn, in addition to possible antagonism of 
inhibitory transmitters30,31.
Sedation is also described as a direct opioid effect. It 
may be desirable and favorable without interfering with mother-
newborn interaction. In a study by Lee et al.22, the majority of 
patients who received local anesthetic alone were reported to be 
awake and anxious, while light sedation with easy arousal was a 
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common finding in those receiving opioid combined with local 
anesthetic, results similar to those obtained in this study. 
Conclusions
Sufentanil 5µg and fentanyl 25µg combined with 
hyperbaric spinal bupivacaine for cesarean section, were equally 
effective in the intraoperative period, without fetal adverse 
effects. Sufentanil provided a longer duration of analgesia and 
motor block. 
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